Annie Yessaian, MD

Title(s)Clinical Assistant Professor of Obstetrics & Gynecology (Clinician Educator)
SchoolKeck School of Medicine of Usc
AddressIRD 520 2020 Zonal Ave
Off Campus
Los Angeles CA 90033
Phone+1 323 226 3183
vCardDownload vCard
    Other Positions
    Title(s)Director of the Gynecology/Oncology Outreach Program


    Collapse Overview 
    Collapse Overview
    Dr. Yessaian graduated from the University of Baghdad Medical School, Iraq in 1989 with high honors. She then further trained in a rotating internship for two years in Baghdad. Dr. Yessaian then joined the residency training program in general surgery at Maimonides Medical Center-Brooklyn NY, where she also received four additional years of obstetrics & gynecology training. She completed her residency in 1998, receiving the award of “Best Chief Resident of the Year. Dr. Yessaian received further training in a research fellowship in molecular biology at Memorial Sloan Kettering Cancer Center, studying platinum resistance in ovarian cancer. She then joined the gynecologic oncology fellowship program at UC Irvine for four more years, where her research areas included angiogenesis in ovarian cancer. Dr. Yessaian received the Society of Gynecologic Oncologist award for best paper presented by a fellow in 2002. In 2004, Dr. Yessaian joined USC as an Assistant professor of clinical Ob-gyn, Gynecologic Oncology. She practices the full scope of gynecological oncology from minimally invasive robotic and fertility sparing surgery, to the ultra-radical surgeries and including chemotherapy, immunotherapy and clinical trials enrollment.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States. Gynecol Oncol. 2023 Oct; 177:1-8. Lee MW, Vallejo A, Mandelbaum RS, Yessaian AA, Pham HQ, Muderspach LI, Roman LD, Klar M, Wright JD, Matsuo K. PMID: 37597497.
      View in: PubMed   Mentions:    Fields:    
    2. Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer. Gynecol Oncol. 2023 06; 173:49-57. Garcia-Sayre J, Lin YG, Matsuo K, Tsao-Wei DD, Mhawech-Fauceglia P, Louie S, Dong T, Ciccone MA, Brunette-Masi LL, Pham HQ, Yessaian AA, Groshen SG, Facio G, Aldana M, Muderspach LI, Garcia AA, Roman LD. PMID: 37079977.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Our Space of Morrow. Int J Gynecol Cancer. 2022 Nov 21. Guo XM, Ciccone MA, Brunette LL, Matsuo K, Pham HQ, Yessaian AA, Muderspach LI, Roman LD. PMID: 36343964.
      View in: PubMed   Mentions:    Fields:    
    4. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2022 Aug; 275:91-96. Matsuo K, Klar M, Khetan VU, Violette CJ, Youssefzadeh AC, Yessaian AA, Roman LD. PMID: 35763967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Side-to-end reanastomosis after low-anterior resection (STELAR): Outcomes, feasibility, and description of procedure performed by a gynecologic oncology service. J Surg Oncol. 2022 Sep; 126(3):563-570. Khetan VU, Muderspach LI, Miller HA, Licon E, Adams CL, Brunette LL, Pham HQ, Yessaian AA, Roman LD, Matsuo K, Ciccone MA. PMID: 35476891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer. Gynecol Oncol. 2022 06; 165(3):428-436. Jooya ND, Ciccone MA, Brunette LL, Pham HQ, Yessaian AA, Muderspach LI, Roman LD, Matsuo K. PMID: 35459549.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Trends and characteristics of ovarian conservation at hysterectomy for young women with cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2022 Jun; 273:59-64. Violette CJ, Mandelbaum RS, Bainvoll L, Joh S, Yessaian AA, Klar M, Paulson RJ, Roman LD, Matsuo K. PMID: 35487095.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery. Radiat Oncol. 2021 Aug 25; 16(1):162. Miller H, Matsuo K, Roman LD, Yessaian AA, Pham HQ, Hom M, Castaneda A, Pham A, Ragab O, Muderspach L, Ciccone M, Brunette LL. PMID: 34433478; PMCID: PMC8390201.
      View in: PubMed   Mentions:    Fields:    
    9. Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery. Radiat Oncol. 2021 Jun 29; 16(1):123. Miller H, Matsuo K, Roman LD, Yessaian AA, Pham HQ, Hom M, Castaneda A, Pham A, Ragab O, Muderspach L, Ciccone M, Brunette LL. PMID: 34187504; PMCID: PMC8244186.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2020 Mar; 246:194-196. Licon E, Matsuzaki S, Opara KN, Ng AJY, Bender NM, Grubbs BH, Lee RH, Ouzounian JG, Pham HQ, Brunette LL, Yessaian AA, Ciccone MA, Muderspach LI, Roman LD, Sasso EB, Matsuo K. PMID: 31959305.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. Gynecol Oncol Rep. 2019 Nov; 30:100497. Blake EA, Ross M, Ihenacho U, Figueroa L, Silverstein E, Flink D, Mendez-Ishizaki Y, Yessaian A, Brunette LL, Matsuo K, Cortessis VK, Guntupalli S, Roman L. PMID: 31692541; PMCID: PMC6804884.
      View in: PubMed   Mentions: 10  
    12. Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma. Pathology. 2018 Aug; 50(5):499-503. Mhawech-Fauceglia P, Walia S, Yessaian A, Machida H, Matsuo K, Lawrenson K. PMID: 29891190; PMCID: PMC7703685.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. J Surg Oncol. 2017 Sep; 116(4):482-491. Matsuo K, Machida H, Ragab OM, Garcia-Sayre J, Yessaian AA, Roman LD. PMID: 28543055; PMCID: PMC7523389.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Gynecol Oncol. 2017 Apr; 145(1):41-49. Matsuo K, Machida H, Takiuchi T, Garcia-Sayre J, Yessaian AA, Roman LD. PMID: 28215841; PMCID: PMC7523224.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Dec; 143(3):650-654. Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG. PMID: 27771165; PMCID: PMC7474546.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome. Int J Gynecol Pathol. 2016 Jul; 35(4):348-51. Mhawech-Fauceglia P, Ramzan A, Walia S, Pham HQ, Yessaian A. PMID: 26598983.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2016 Feb; 26(2):290-300. Matsuo K, Jung CE, Hom MS, Gualtieri MR, Randazzo SC, Kanao H, Yessaian AA, Roman LD. PMID: 26569058; PMCID: PMC7526043.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman LD, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. PMID: 26360252; PMCID: PMC4658296.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    19. Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy. Cancer Microenviron. 2014 Aug; 7(1-2):33-9. Mhawech-Fauceglia P, Wang D, Samrao D, Kim G, Lawrenson K, Meneses T, Liu S, Yessaian A, Pejovic T. PMID: 24214412; PMCID: PMC4150876.
      View in: PubMed   Mentions: 14  
    20. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman LD. PMID: 23262205.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    21. Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy. Transl Oncol. 2012 Dec; 5(6):469-74. Samrao D, Wang D, Ough F, Lin YG, Liu S, Menesses T, Yessaian A, Turner N, Pejovic T, Mhawech-Fauceglia P. PMID: 23397476; PMCID: PMC3567723.
      View in: PubMed   Mentions: 13  
    22. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman LD. PMID: 22228425.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    23. Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer. Oncologist. 2012; 17(12):1598-9. Matsuo K, Blake EA, Yessaian AA, Roman LD. PMID: 23263923; PMCID: PMC3528394.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Population characteristics in cervical cancer trials: search for external validity. Am J Obstet Gynecol. 2005 Feb; 192(2):407-13. Yessaian A, Mendivil AA, Brewster WR. PMID: 15695979.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    25. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecol Oncol. 2004 Jul; 94(1):61-6. Yessaian A, Magistris A, Burger RA, Monk BJ. PMID: 15262120.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Annie's Networks
    Concepts (116)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.